ArticleThe Journal of clinical investigation2026

Targeting GLP-1R and IL-17A suppresses obesity-induced leukemia in an oncogenic PTPN11 mutation-driven model.

Reuben Kapur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.